F9 and hemophilia B: Similarly, hiPSCs derived from a hemophilia B patient with the targeted insertion of the coagulation factor IX (F-IX) into the AAVS1 locus readily differentiated into hepatocytes capable of stable F-IX secretion and short-term functional activity after engraftment into NOD/SCID mice [180].